ResTORbio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ResTORbio and buy or sell other stocks, ETFs, and their options commission-free!

About TORC

resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. 

CEO
Chen Schor, MBA, CPA
CEOChen Schor, MBA, CPA
Employees
152
Employees152
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2016
Founded2016
Employees
152
Employees152

TORC Key Statistics

Market cap
268.81M
Market cap268.81M
Price-Earnings ratio
-0.58
Price-Earnings ratio-0.58
Dividend yield
—
Dividend yield—
Average volume
1.10M
Average volume1.10M
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$1.70
52 Week high$1.70
52 Week low
$0.4471
52 Week low$0.4471

People also own

Based on the portfolios of people who own TORC. This list is generated using Robinhood data, and it’s not a recommendation.
Genius Brands
Ideanomics
iBio
Onconova Therapeutics
Verastem
Inpixon
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.